Neural Cell News Volume 8.35 | Sep 10 2014

    0
    22

    Neural Cell News 8.35 September 10, 2014

    Neural Cell News

         In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  NCN on Twitter

     
    TOP STORY
    In Directing Stem Cells, Study Shows Context Matters
    Investigators show that a soft, brain tissue-like surface, independent of any soluble factors, was catalyst enough to direct cells to become neurons, the large elaborate cells that make up the central nervous system. Stiffer surfaces favored the stem cell state. [Press release from the University of Wisconsin discussing online prepublication in Proceedings of the National Academy of Sciences] Press Release | Abstract
    Webinar: Brent Reynolds on Identification and Characterization of Neural Stem Cells

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Local CRH Signaling Promotes Synaptogenesis and Circuit Integration of Adult-Born Neurons
    With the goal of identifying signaling mechanisms that underlie neuronal circuit integration in the adult brain, researchers have virally traced local corticotropin-releasing hormone (CRH)-expressing inhibitory interneurons with extensive presynaptic inputs onto new neurons that are continuously integrated into the adult rodent olfactory bulb. [Dev Cell] Abstract | Graphical Abstract

    AMPK Modulates Tissue and Organismal Aging in a Non-Cell-Autonomous Manner
    The authors show that upregulation of AMPK in the adult Drosophila nervous system induces autophagy both in the brain and also in the intestinal epithelium. Neuronal upregulation of the autophagy-specific protein kinase Atg1 is both necessary and sufficient to induce these intertissue effects during aging and to prolong the lifespan. [Cell Rep] Full Article | Graphical Abstract | Press Release

    CHD7 Maintains Neural Stem Cell Quiescence and Prevents Premature Stem Cell Depletion in the Adult Hippocampus
    Using an inducible knockout mouse model, scientists show that the chromatin remodeling factor chromodomain-helicase-DNA-binding protein 7 (CHD7) is essential for maintaining neural stem/progenitor cell (NSC) quiescence. CHD7 inactivation in adult NSCs results in a loss of stem cell quiescence in the hippocampus, a transient increase in cell divisions, followed by a significant decline in neurogenesis. [Stem Cells] Abstract

    Spinal Cord Injury Enables Aromatic L-Amino Acid Decarboxylase Cells to Synthesize Monoamines
    Investigators show by immunohistochemical techniques that cells containing the enzyme aromatic L-amino acid decarboxylase (AADC) occur not only near the central canal, but also in the intermediate zone and dorsal horn of the spinal gray matter. Following complete transection of the rat spinal cord at S2 level, they show that AADC cells distal to the lesion acquire the ability to produce serotonin from its immediate precursor,
    5-hydroxytryptophan. [J Neurosci]
    Abstract | Press Release

    Neurotensin Signaling Regulates Stem-Like Traits of Glioblastoma Stem Cells through Activation of
    IL-8/CXCR1/STAT3 Pathway

    Scientists previously found that neurotensin and its primary receptor NTSR1 play a crucial role in glioblastoma cell proliferation and invasion. Now they show that NTSR1 is higher expressed in glioblastoma stem cells (GSCs) than their non-GSC counterparts. [Cell Signal] Abstract

    CRM197 in Combination with shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells
    Researchers investigated the role and mechanism of CRM197 combined with shRNA interference of vascular cell adhesion molecule-1 (VCAM-1) on the migration, invasion and apoptosis of glioblastoma cells. [J Cell Physiol] Abstract

    Migration and Differentiation of Neural Progenitor Cells after Recurrent Laryngeal Nerve Avulsion in Rats
    Scientists investigated migration and differentiation of neural progenitor cells from the ependymal layer to the nucleus ambiguus after recurrent laryngeal nerve avulsion. [PLoS One] Full Article

    EGCG Inhibits Properties of Glioma Stem-Like Cells and Synergizes with Temozolomide through Downregulation of P-Glycoprotein Inhibition
    Investigators examined the molecular mechanisms by which epigallocatechin gallate (EGCG), a bioactive polyphenol in green tea, inhibits the stem cell characteristics of glioma stem-like cells and synergizes with temozolomide, a DNA-methylating agent commonly used as first-line chemotherapy in gliomas. [J Neurooncol] Abstract

    Reversal of Cellular Phenotypes in Neural Cells Derived from Huntington’s Disease Monkey-Induced Pluripotent Stem Cells
    Scientists report the establishment of neural progenitor cell lines derived from induced pluripotent stem cells of transgenic Huntington’s disease (HD) monkeys. Upon differentiation to neurons, HD neural cells develop cellular features of HD, including the formation of nuclear inclusions and oligomeric mutant huntingtin protein aggregates, as well as increased apoptosis. [Stem Cell Rep] Full Article | Graphical Abstract | Press Release

    Your Free Copy of the Nature Neuroscience Poster "Neural Stem Cells" Awaits

     
    REVIEWS
    The Role of Glial Cells and the Complement System in Retinal Diseases and Alzheimer’s Disease: Common Neural Degeneration Mechanisms
    The authors discuss the common roles of the complement system (an immunological system) and glial cells (providing, amongst other functions, trophic support to neurons) in three disorders: age-related macular degeneration, glaucoma and Alzheimer’s disease. [Exp Brain Res] Abstract

    Visit our reviews page to see a complete list of reviews in the neural cell research field.

    Cell Culture World Congress Asia 2014

     
    SCIENCE NEWS
    New Data Show In Vivo Induction of Remyelination in Animal Model of Multiple Sclerosis (MS)
    ENDECE Neural announced the presentation of new, pre-clinical evidence that the company’s lead compound, NDC-1308, induces remyelination in vivo in a validated animal model of demyelination. [Press release from ENDECE LLC discussing research to be presented at the 2014 Joint Meeting of the American and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS/ECTRIMS), Boston] Press Release

    Gilenya® Data Confirm Reducing Brain Shrinkage Matters for People with MS Due to Its Association with Long-Term Disability Progression
    Novartis announced new data that reinforces the clinical importance of measuring brain shrinkage (brain volume loss) in multiple sclerosis (MS). [Press release from Novartis AG discussing research presented at the 2014 Joint Meeting of the American and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS/ECTRIMS), Boston] Press Release

    From our sponsor: Pluripotent cell isolation for regenerative medicine. Request a free wallchart from Nature.

     
    INDUSTRY NEWS
    Herbert Irving Comprehensive Cancer Center Has Designation Renewed by National Cancer Institute; Awarded $18 Million Grant
    Outstanding basic research, a growing focus on translating discoveries into treatments, and a dedication to patient care have earned the Herbert Irving Comprehensive Cancer Center of Columbia University Medical Center and New York-Presbyterian Hospital an $18 million, five-year Cancer Center Support Grant from the National Cancer Institute. [Columbia University Medical Center] Press Release

    Bella Bowman Foundation Donates $75K to LSU Medical Physics Program
    The Bella Bowman Foundation announced a $75,000 grant to the LSU Medical Physics program, in partnership with the Mary Bird Perkins Cancer Center, to establish the Bella Bowman Foundation Radiation Necrosis Research Fund to examine the risks of radiation injuries to the brain as a result of proton radiation therapy. [The Bella Bowman Foundation] Press Release

    BrainStorm Granted European Patent Covering Its Stem Cells for the Treatment of CNS Diseases
    BrainStorm Cell Therapeutics announced that the European Patent Office has granted the company patent number EP1893747, entitled “Isolated Cells and Populations Comprising Same for the Treatment of CNS Diseases.” [BrainStorm Cell Therapeutics, Inc.] Press Release

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW 13th Annual AACR International Conference on Frontiers in Cancer Prevention Research
    September 28-October 1, 2014
    New Orleans, United States

    Visit our events page to see a complete list of events in the neural cell community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Fellow – Tissue Engineering & Spinal Cord Injury (Nanyang Technological University)

    NEW Postdoctoral Fellow – Developmental Stem Cell and Cancer Biology (North Carolina College of Veterinary Medicine)

    NEW Postdoctoral Fellow – Stem Cells and Neurodegeneration (University of Copenhagen)

    Postdoctoral Candidate – Dynamic Organization of Synapses (INSERM)

    Postdoctoral Fellow – Molecular/Cellular Neuroscience (Center for Applied Medical Research, University of Navarra)

    Postdoctoral Fellow – Role of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis (Pfizer)

    Postdoctoral Fellow – Stem Cell Biology (The University of Texas Medical School At Houston)

    Postdoctoral Positions – The Development of Human Cortical Neurons and Synapses (Free University of Brussels)

    Postdoctoral Fellowship (Medical University of South Carolina)

    Research Associate – Neuroscience (University of Cambridge)

    Scientist – Human Pluripotent Stem Cell Neural Differentiation (STEMCELL Technologies Inc.)

    Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

    Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

    Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)

    Research Associate – Cell Separation (STEMCELL Technologies Inc.)

    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Neural Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Neural Cell News: Archives | Events | Contact Us